Outset Medical
Update in progressOM (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Outset Medical, Inc. develops the Tablo Hemodialysis System for use in the United States. The compact console includes integrated water purification, on-demand dialysate production, software, and connectivity. It manufactures, supports, and distributes the Tablo console, Tablo cartridges, and related consumables. The company also offers the Tablo Data Ecosystem—TabloHub, MyTablo, and TabloDash. Formerly Home Dialysis Plus, it was renamed in 2015, is incorporated since 2003, and is based in San Jose, California.
Company score
- Sentiment
- -0.03
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.10
- Governance
- -0.32
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.04
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!